1544P A phase II trial of palbociclib and avelumab in advanced solid tumours with CDK4/6 pathway alterationsM. Kansara, D. Thomas, James J. Grady et al.|Annals of Oncology|2025Cited by 1
636P Tucatinib and trastuzumab in advanced cancers with HER2 mutations or amplification: A molecular screening and therapeutics (MoST) program substudyBenjamin Y. Kong, David Goldstein, Frank Lin et al.|Annals of Oncology|2024Cited by 0